These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10778968)

  • 1. Concentrations of galectin-3 in the sera of normal controls and cancer patients.
    Iurisci I; Tinari N; Natoli C; Angelucci D; Cianchetti E; Iacobelli S
    Clin Cancer Res; 2000 Apr; 6(4):1389-93. PubMed ID: 10778968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
    Bresalier RS; Byrd JC; Wang L; Raz A
    Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.
    Inohara H; Akahani S; Koths K; Raz A
    Cancer Res; 1996 Oct; 56(19):4530-4. PubMed ID: 8813152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
    Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
    Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteoprotegerin levels in healthy controls and cancer patients.
    Lipton A; Ali SM; Leitzel K; Chinchilli V; Witters L; Engle L; Holloway D; Bekker P; Dunstan CR
    Clin Cancer Res; 2002 Jul; 8(7):2306-10. PubMed ID: 12114435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.
    Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S
    J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
    Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
    Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.
    Kawachi K; Matsushita Y; Yonezawa S; Nakano S; Shirao K; Natsugoe S; Sueyoshi K; Aikou T; Sato E
    Hum Pathol; 2000 Apr; 31(4):428-33. PubMed ID: 10821488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of galectin-3 in cancer apoptosis.
    Nakahara S; Oka N; Raz A
    Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum galectin-3 in advanced melanoma: preliminary results.
    Vereecken P; Zouaoui Boudjeltia K; Debray C; Awada A; Legssyer I; Sales F; Petein M; Vanhaeverbeek M; Ghanem G; Heenen M
    Clin Exp Dermatol; 2006 Jan; 31(1):105-9. PubMed ID: 16309497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure.
    Christenson RH; Duh SH; Wu AH; Smith A; Abel G; deFilippi CR; Wang S; Adourian A; Adiletto C; Gardiner P
    Clin Biochem; 2010 May; 43(7-8):683-90. PubMed ID: 20153309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
    Kopp R; Classen S; Wolf H; Gholam P; Possinger K; Wilmanns W
    Anticancer Res; 2001; 21(4B):2995-3000. PubMed ID: 11712800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
    Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
    Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma.
    Suarez-Alvarez B; Garcia Suarez MM; Argüelles ME; Sampedro A; Alvarez Marcos C; Mira E; Van den Brul FA; Liu FT; Chowdhury PS; de los Toyos JR
    Anticancer Res; 2001; 21(5):3677-84. PubMed ID: 11848542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.
    Honjo Y; Inohara H; Akahani S; Yoshii T; Takenaka Y; Yoshida J; Hattori K; Tomiyama Y; Raz A; Kubo T
    Clin Cancer Res; 2000 Dec; 6(12):4635-40. PubMed ID: 11156213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 expression in colorectal cancer: relation to invasion and metastasis.
    Tsuboi K; Shimura T; Masuda N; Ide M; Tsutsumi S; Yamaguchi S; Asao T; Kuwano H
    Anticancer Res; 2007; 27(4B):2289-96. PubMed ID: 17695516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum 90K and Galectin-3 expression are associated with advanced stage and a worse prognosis in diffuse large B-cell lymphomas.
    Kim SJ; Lee SJ; Sung HJ; Choi IK; Choi CW; Kim BS; Kim JS; Yu W; Hwang HS; Kim IS
    Acta Haematol; 2008; 120(4):211-6. PubMed ID: 19153476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.